Gene therapy may treat obesity
By Times of India,
Times of India
| 03. 10. 2009
Alarmed by the rise in obesity, researchers are examining the possibility of injecting a gene directly into one of the critical feeding and weight control centres of the brain.
"Obesity significantly increases the risk for diabetes, cardiovascular disease, stroke and some cancers," said Matthew During, the study's co-author and professor at Ohio State University Medical Centre.
"Our findings represent a promising new treatment for obesity that could ultimately provide a much safer and more effective approach than some conventional therapies," he said.
Scientists have discovered that a particular gene, BDNF, when active in the hypothalamus, can result in improved insulin sensitivity, reduced fat mass and weight loss.
Lei Cao, a co-author and assistant professor of molecular virology, immunology and medical genetics, said the study involved injecting the BDNF gene in normal mice, diabetic mice and mice fed with a high fat diet, to determine how the gene transfer would affect their weight.
"The gene was active in the overweight mice but as they lost weight, the gene expression was essentially 'dialed down,' using a novel RNA interference approach, thus stopping...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...